Disorders of peroxisome biogenesis
Non-billable header
E71.51 is a non-billable header code. Use one of the more specific codes below.
Inclusion terms
Applicable to
- Group 1 peroxisomal disorders
Includes (from E71)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- Refsum's disease (G60.1)
- Schilder's disease (G37.0) (from E71.5)
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E71)
- androgen insensitivity syndrome (E34.5-) (from E71)
- congenital adrenal hyperplasia (E25.0) (from E71)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E71)
- Marfan syndrome (Q87.4-) (from E71)
- 5-alpha-reductase deficiency (E29.1) (from E71)
Excludes2
Not included here — may be reported together when both conditions exist.
Also known as
- Group 1 peroxisomal disorders